Oliver J Liakopoulos1, Wael Ahmad2. 1. Department of Cardiac Surgery, Kerckhoff-Clinic Bad Nauheim, Campus Kerckhoff, University of Giessen, Bad Nauheim, Germany. 2. Department of Vascular and Endovascular Surgery, University Hospital of Cologne, Cologne, Germany.
Oliver J. Liakopoulos, MD, and Wael Ahmad, MDThis case report demonstrates the feasibility of a one-step hybrid repair approach of acute type A dissection with visceral malperfusion.See Article page 22.Mesenteric malperfusion syndrome (MMP) caused by acute type A dissection (AAD) is a rare, often clinically silent and fatal complication. In the prospective, multicentric German Registry for Acute Aortic Dissection Type A and the International Registry for Acute Dissection (IRAD), mesenteric malperfusion was present in 5.8% (2137 patients) and 3.8% (1809 patients), respectively., As reported from the IRAD registry, hospital mortality was 95% with medical (conservative) therapy, 72% after endovascular, and 42% after surgical/hybrid treatment of AAD complicated by MMP and ultimately linked to a 3- to 4-fold greater mortality compared with patients without malperfusion., Strikingly, approximately 50% of patients with MMP in the IRAD registry did not receive a surgical treatment, despite the dismal results of a watchful-wait strategy.The optimal management of AAD with MMP still remains controversial, and current surgical strategies include immediate proximal aortic repair with or without laparotomy, immediate proximal aortic repair with downstream endovascular repair of the aorta (endovascular-second strategy), and downstream endovascular repair first with delayed open surgical repair of the ascending aorta/arch (endovascular-first strategy). Indeed, primary restoration of mesenteric perfusion with thoracic endovascular aortic repair or endovascular aortic fenestration without mesenteric vessel stenting has been recently proposed by 2 independent groups from Emory and Michigan in selected patients with stable AAD (ie, stable hemodynamics; no pericardial tamponade, aortic rupture or severe aortic regurgitation)., The key advantage of the endovascular-first approach is that it offers a potential “bridge to decision” in stable patients and may avoid a futile open aortic surgery in the presence of a deleterious and irreversible mesenteric ischemia. On the downside, this strategy is not feasible in the majority of patients with AAD presenting with unstable hemodynamics, pericardial effusion, or aortic insufficiency,, or in centers without or only limited access to experienced endovascular surgeons.In this issue of the Journal, Ni and colleagues have evolved the endovascular-first technique to a one-step hybrid approach in a patient presenting with AAD complicated by severe aortic regurgitation, occlusion of the superior mesenteric artery, and right renal artery. The patient underwent, in a hybrid room setting, endovascular bare-metal stenting of the superior mesenteric artery and right renal artery with successful restoration of visceral reperfusion. Subsequently, aortic root repair was completed and circulatory arrest for extensive arch repair was avoided by debranching of the supra-aortic vessels following endovascular arch repair with thoracic endovascular aortic repair (landing zone 0). The clinical course of the patient was uneventful and postoperative computed tomography scans before discharge revealed patent visceral vessels. The authors can be congratulated for their hybrid strategies that demonstrate the feasibility and efficacy of combining conventional aortic surgery with advanced endovascular repair in extensive AAD with MMP. Importantly, the successful one-step combination of both techniques underscores the importance of a dedicated aortic team with profound expertise in hybrid aortic repair techniques. Whether the endovascular-first strategy and one-stage hybrid approach will ultimately lead to improved outcomes in patients with AAD complicated by MMP when compared with conventional strategies needs to be evaluated in much larger series.
Authors: Martin Czerny; Florian Schoenhoff; Christian Etz; Lars Englberger; Nawid Khaladj; Andreas Zierer; Ernst Weigang; Isabell Hoffmann; Maria Blettner; Thierry P Carrel Journal: J Am Coll Cardiol Date: 2015-06-23 Impact factor: 24.094
Authors: Bradley G Leshnower; W Brent Keeling; Yazan M Duwayri; William D Jordan; Edward P Chen Journal: J Thorac Cardiovasc Surg Date: 2019-02-11 Impact factor: 5.209
Authors: Marco Di Eusanio; Santi Trimarchi; Himanshu J Patel; Stuart Hutchison; Toru Suzuki; Mark D Peterson; Roberto Di Bartolomeo; Gianluca Folesani; Reed E Pyeritz; Alan C Braverman; Daniel G Montgomery; Eric M Isselbacher; Christoph A Nienaber; Kim A Eagle; Rossella Fattori Journal: J Thorac Cardiovasc Surg Date: 2012-02-15 Impact factor: 5.209
Authors: Bo Yang; Carlo Maria Rosati; Elizabeth L Norton; Karen M Kim; Minhaj S Khaja; Narasimham Dasika; Xiaoting Wu; Whitney E Hornsby; Himanshu J Patel; G Michael Deeb; David M Williams Journal: Circulation Date: 2018-11-06 Impact factor: 29.690